68Ga-NODAGA-E[c(RGDγK)]2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-NODAGA-E[c(RGDγK)]2, covering 2023-11-21 to 2023-11-21. Get the full timeline:
Most recent: Clinical Trial Update: 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease [Phase 2]